Does This New Development Make CVS Stock a Buy or a Sell?

With rumors swirling about CVS Health's (NYSE: CVS) new and ongoing discussions on how to turn around the company's sagging fortunes, it's natural for investors to wonder whether there's a new flurry of risks on the way, or there are whiffs of fresh opportunity in the air.Management's final plan doesn't appear to be wrapped up just yet, but analyzing the challenges faced by the business -- as well as the actions that it's already taking -- should help to clarify whether this stock is more likely to be a buy or a sell in the near future. Let's dive in and see.In the past five years, CVS stock has achieved a dispappointing total return of just 14%, dramatically lagging the market's growth of 110%. So it's clear that shareholders have reason to be concerned, because there has been a disconnect between the company's strategy and its returns, especially since the start of 2023.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool